Discover open access scientific publications

Search, annotate, share and cite publications

Publications by T. Hida

LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma

Cancer Research

Cancer Research

English

OA08.01 Long-Term Efficacy and Safety of Nivolumab in Second- Or Third-Line Japanese Malignant Pleural Mesothelioma Patients (Phase II: MERIT Study)

Journal of Thoracic Oncology

Respiratory Medicine

English

MA 17.06 Safety Data From Randomized Phase II Study of CDDP+S-1 vs CDDP+PEM Combined With TRT for Locally Advanced Non-Squamous NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-35 Tumor Volume Analysis in ALK-Rearranged NSCLC Treated With Crizotinib: Identifying an Early Marker for Clinical Outcome

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.01-73 Automated Image Analysis Tool for Tumor Volume Growth Rate to Guide Precision Cancer Therapy: EGFR-Mutant NSCLC as a Paradigm

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-34 Docetaxel Plus Ramucirumab With Prophylactic PEG-G-CSF Support for Chemo-NaïVe Elderly NSCLC Patients: A Phase II Study (WJOG9416L)

Journal of Thoracic Oncology

Respiratory Medicine

English

P083 Efficacy of EGFR-TKIs in Patients Harboring EGFR Mutations With Non-Adenocartinoma Histology

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.15-004 Underrepresentation of Elderly Patients With ED-SCLC as Clinical Trial Candidates (JCOG1201/TORG1528)

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-28 Impact of Afatinib Dosing on Safety and Efficacy Real-World in Patients With EGFR Mutation-Positive Advanced NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

P072 Low Detection Rate of EGFR Driver and T790M Mutation in Plasma by Cobas V2 After Acquired Resistance to Afatinib

Journal of Thoracic Oncology

Respiratory Medicine

English